Don Tracy, Associate Editor

Biden Administration invokes Defense Production Act to facilitate domestic manufacturing of essential medicines.

Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.

Medication focuses on the acute treatment of migraines.

Study emphasizes role in bridging research and development and commercial/marketing functions.

Study estimates that up to 20% of the costs for clinical research is associated with the manual transfer and verification of data from the electronic medical record to a data capture system.

Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.

Studies with Zenith-CKD showed significant albuminuria reduction.

SLS009 is a novel CDK9 inhibitor under investigation for the treatment of relapsed/refractory peripheral T-cell lymphomas.

Furmonertinib is in development for the treatment of advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.

Session offers insight on how to successfully implement cold chain transport.

Panel discusses how digital transformation can best impact supply chains.

Pharma Commerce provides a synopsis of the presentation.

In this breakout session, industry leaders discuss understanding and overcoming errors brought on by data challenges.

Pharma Commerce provides a summary of conference breakout session.

Pharma Commerce offers a synopsis of some of the conference’s events.

Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.